Israel Active

The US Academy for Health and Lifespan Research (AHLR) has inducted Prof. Haim Cohen of Israel’s Bar-Ilan University. “It's inspiring to be part of such a remarkable group of scientists, all working to advance aging research and improve lives around the world,” said Prof. Cohen.

A study by researchers at Israel’s Ben-Gurion University has found that although over a quarter of people on a diet do not lose weight, they gain other health benefits. These include higher “good” cholesterol, lower leptin levels, and reduced visceral and liver fat. So be positive!

Researchers from Tel Aviv University (TAU) and Sheba Medical Center have developed replacement skin for grafting in burn victims. Bioengineered from the patient’s own cells, it is stable, robust, and flexible and can achieve wound closure in half the time of standard therapies.

Israel’s PolyPid (see previously) reported positive Phase III trial results on its delayed-release antibiotic treatment applied at the site of surgical infections. The reduction in the risk of infection after surgery was 58% in the 800-patient trial.

Prof Liat Ayalon, of Israel’s Bar-Ilan University, is one of the United Nations’ Healthy Ageing 50: leaders transforming the world to be a better place to grow older. She has just been awarded a 2.5 million Euro grant from the European Research Council to advance her HALFLIFE project.  

A third of 97 “terminal” myeloma patients are still alive after five years thanks to Car-T cancer treatment, originally invented by Israeli scientists. These were the findings of an international study, including Israel’s Sourasky (Ichilov) Medical Center.

Israel’s MeMed (see previously) reached a major milestone of more than 100,000 patients tested with its MeMed BV, the company’s flagship technology that accurately distinguishes between bacterial and viral infections in just 15 minutes.

For decades, scientists believed that paracetamol relieved discomfort by working only in the brain and spinal cord. Now, Hebrew University of Jerusalem scientists show that the AM404 active metabolite which it releases, shuts off sodium channels to stop pain signals while they are still at nerve endings.

Dozens of doctors, who were at a European medical conference, have boarded a merchant ship on a special rescue voyage back to Israel. Among them are doctors from Sourasky (Ichilov) Medical Center, Rambam Health Care Campus, and Sheba Medical Center.

Israel’s Ben-Gurion University has partnered with the Sagol Network to launch the Sagol Medical School for International Health. Its 4-year MD program, open to all Israeli citizens, uses hi-tech, global health, and AI to train Israel’s medical leaders. Currently, some 160 students are enrolled in the school.